Helsinn appoints Mary Lynne Hedley to Board of Directors
29 avr. 2021 03h00 HE
|
Helsinn Healthcare S.A.
Lugano, Switzerland, April 29, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to announce the appointment of Dr. Mary Lynne...